Upregulation of Monocyte/Macrophage HGFIN (Gpnmb/Osteoactivin) Expression in End-Stage Renal Disease
Hematopoietic growth factor-inducible neurokinin 1 (HGFIN), also known as Gpnmb and osteoactivin, is a transmembrane glycoprotein that is expressed in numerous cells, including osteoclasts, macrophages, and dendritic cells. It serves as an osteoblast differentiation factor, participates in bone mine...
Saved in:
Published in | Clinical journal of the American Society of Nephrology Vol. 5; no. 1; pp. 56 - 61 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society of Nephrology
01.01.2010
|
Series | Original Articles |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Hematopoietic growth factor-inducible neurokinin 1 (HGFIN), also known as Gpnmb and osteoactivin, is a transmembrane glycoprotein that is expressed in numerous cells, including osteoclasts, macrophages, and dendritic cells. It serves as an osteoblast differentiation factor, participates in bone mineralization, and functions as a negative regulator of inflammation in macrophages. Although measurable at low levels in monocytes, monocyte-to-macrophage transformation causes substantial increase in HGFIN expression. HGFIN is involved in systemic inflammation, bone demineralization, and soft tissue vascular calcification.
We explored HGFIN expression in monocytes and monocyte-derived macrophages in 21 stable hemodialysis patients and 22 control subjects.
Dialysis patients exhibited marked upregulation of colony-stimulating factor and IL-6 and significant downregulation of IL-10 in intact monocytes and transformed macrophages. HGFIN expression in intact monocytes was negligible in control subjects but conspicuously elevated (8.6-fold) in dialysis patients. As expected, in vitro monocyte-to-macrophage transformation resulted in marked upregulation of HGFIN in cells obtained from both groups but much more so in dialysis patients (17.5-fold higher). Upregulation of HGFIN and inflammatory cytokines in the uremic monocyte-derived macrophages occurred when grown in the presence of either normal or uremic serum, suggesting the enduring effect of the in vivo uremic milieu on monocyte/macrophage phenotype and function.
Uremic macrophages exhibit increased HGFIN gene and protein expression and heightened expression of proinflammatory and a suppressed expression of anti-inflammatory cytokines. Further studies are needed to determine the role of heightened monocyte/macrophage HGFIN expression in the pathogenesis of ESRD-induced inflammation and vascular and soft tissue calcification. |
---|---|
AbstractList | Hematopoietic growth factor-inducible neurokinin 1 (HGFIN), also known as Gpnmb and osteoactivin, is a transmembrane glycoprotein that is expressed in numerous cells, including osteoclasts, macrophages, and dendritic cells. It serves as an osteoblast differentiation factor, participates in bone mineralization, and functions as a negative regulator of inflammation in macrophages. Although measurable at low levels in monocytes, monocyte-to-macrophage transformation causes substantial increase in HGFIN expression. HGFIN is involved in systemic inflammation, bone demineralization, and soft tissue vascular calcification.BACKGROUND AND OBJECTIVESHematopoietic growth factor-inducible neurokinin 1 (HGFIN), also known as Gpnmb and osteoactivin, is a transmembrane glycoprotein that is expressed in numerous cells, including osteoclasts, macrophages, and dendritic cells. It serves as an osteoblast differentiation factor, participates in bone mineralization, and functions as a negative regulator of inflammation in macrophages. Although measurable at low levels in monocytes, monocyte-to-macrophage transformation causes substantial increase in HGFIN expression. HGFIN is involved in systemic inflammation, bone demineralization, and soft tissue vascular calcification.We explored HGFIN expression in monocytes and monocyte-derived macrophages in 21 stable hemodialysis patients and 22 control subjects.DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTSWe explored HGFIN expression in monocytes and monocyte-derived macrophages in 21 stable hemodialysis patients and 22 control subjects.Dialysis patients exhibited marked upregulation of colony-stimulating factor and IL-6 and significant downregulation of IL-10 in intact monocytes and transformed macrophages. HGFIN expression in intact monocytes was negligible in control subjects but conspicuously elevated (8.6-fold) in dialysis patients. As expected, in vitro monocyte-to-macrophage transformation resulted in marked upregulation of HGFIN in cells obtained from both groups but much more so in dialysis patients (17.5-fold higher). Upregulation of HGFIN and inflammatory cytokines in the uremic monocyte-derived macrophages occurred when grown in the presence of either normal or uremic serum, suggesting the enduring effect of the in vivo uremic milieu on monocyte/macrophage phenotype and function.RESULTSDialysis patients exhibited marked upregulation of colony-stimulating factor and IL-6 and significant downregulation of IL-10 in intact monocytes and transformed macrophages. HGFIN expression in intact monocytes was negligible in control subjects but conspicuously elevated (8.6-fold) in dialysis patients. As expected, in vitro monocyte-to-macrophage transformation resulted in marked upregulation of HGFIN in cells obtained from both groups but much more so in dialysis patients (17.5-fold higher). Upregulation of HGFIN and inflammatory cytokines in the uremic monocyte-derived macrophages occurred when grown in the presence of either normal or uremic serum, suggesting the enduring effect of the in vivo uremic milieu on monocyte/macrophage phenotype and function.Uremic macrophages exhibit increased HGFIN gene and protein expression and heightened expression of proinflammatory and a suppressed expression of anti-inflammatory cytokines. Further studies are needed to determine the role of heightened monocyte/macrophage HGFIN expression in the pathogenesis of ESRD-induced inflammation and vascular and soft tissue calcification.CONCLUSIONSUremic macrophages exhibit increased HGFIN gene and protein expression and heightened expression of proinflammatory and a suppressed expression of anti-inflammatory cytokines. Further studies are needed to determine the role of heightened monocyte/macrophage HGFIN expression in the pathogenesis of ESRD-induced inflammation and vascular and soft tissue calcification. Background and objectives: Hematopoietic growth factor–inducible neurokinin 1 (HGFIN), also known as Gpnmb and osteoactivin, is a transmembrane glycoprotein that is expressed in numerous cells, including osteoclasts, macrophages, and dendritic cells. It serves as an osteoblast differentiation factor, participates in bone mineralization, and functions as a negative regulator of inflammation in macrophages. Although measurable at low levels in monocytes, monocyte-to-macrophage transformation causes substantial increase in HGFIN expression. HGFIN is involved in systemic inflammation, bone demineralization, and soft tissue vascular calcification. Design, setting, participants, & measurements: We explored HGFIN expression in monocytes and monocyte-derived macrophages in 21 stable hemodialysis patients and 22 control subjects. Results: Dialysis patients exhibited marked upregulation of colony-stimulating factor and IL-6 and significant downregulation of IL-10 in intact monocytes and transformed macrophages. HGFIN expression in intact monocytes was negligible in control subjects but conspicuously elevated (8.6-fold) in dialysis patients. As expected, in vitro monocyte-to-macrophage transformation resulted in marked upregulation of HGFIN in cells obtained from both groups but much more so in dialysis patients (17.5-fold higher). Upregulation of HGFIN and inflammatory cytokines in the uremic monocyte-derived macrophages occurred when grown in the presence of either normal or uremic serum, suggesting the enduring effect of the in vivo uremic milieu on monocyte/macrophage phenotype and function. Conclusions: Uremic macrophages exhibit increased HGFIN gene and protein expression and heightened expression of proinflammatory and a suppressed expression of anti-inflammatory cytokines. Further studies are needed to determine the role of heightened monocyte/macrophage HGFIN expression in the pathogenesis of ESRD-induced inflammation and vascular and soft tissue calcification. Hematopoietic growth factor-inducible neurokinin 1 (HGFIN), also known as Gpnmb and osteoactivin, is a transmembrane glycoprotein that is expressed in numerous cells, including osteoclasts, macrophages, and dendritic cells. It serves as an osteoblast differentiation factor, participates in bone mineralization, and functions as a negative regulator of inflammation in macrophages. Although measurable at low levels in monocytes, monocyte-to-macrophage transformation causes substantial increase in HGFIN expression. HGFIN is involved in systemic inflammation, bone demineralization, and soft tissue vascular calcification. We explored HGFIN expression in monocytes and monocyte-derived macrophages in 21 stable hemodialysis patients and 22 control subjects. Dialysis patients exhibited marked upregulation of colony-stimulating factor and IL-6 and significant downregulation of IL-10 in intact monocytes and transformed macrophages. HGFIN expression in intact monocytes was negligible in control subjects but conspicuously elevated (8.6-fold) in dialysis patients. As expected, in vitro monocyte-to-macrophage transformation resulted in marked upregulation of HGFIN in cells obtained from both groups but much more so in dialysis patients (17.5-fold higher). Upregulation of HGFIN and inflammatory cytokines in the uremic monocyte-derived macrophages occurred when grown in the presence of either normal or uremic serum, suggesting the enduring effect of the in vivo uremic milieu on monocyte/macrophage phenotype and function. Uremic macrophages exhibit increased HGFIN gene and protein expression and heightened expression of proinflammatory and a suppressed expression of anti-inflammatory cytokines. Further studies are needed to determine the role of heightened monocyte/macrophage HGFIN expression in the pathogenesis of ESRD-induced inflammation and vascular and soft tissue calcification. |
Author | Jun Yuan Nosratola D. Vaziri Sharon G. Adler Madeleine V. Pahl |
Author_xml | – sequence: 1 givenname: Madeleine V. surname: Pahl fullname: Pahl, Madeleine V. – sequence: 2 givenname: Nosratola D. surname: Vaziri fullname: Vaziri, Nosratola D. – sequence: 3 givenname: Jun surname: Yuan fullname: Yuan, Jun – sequence: 4 givenname: Sharon G. surname: Adler fullname: Adler, Sharon G. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19833906$$D View this record in MEDLINE/PubMed |
BookMark | eNptkUtv1DAUhS3Uij5gxxplgwCJdPyInWRTCQ3TaVEfUqESO8txbmZcOXaIPYX-ezyddgSoK9vy-c69OucA7TjvAKE3BB9RSvhk-vXyCDNWY47rF2ifcM7z9Pixs70XZA8dhHCLcVEwyl-iPVJXa0Lso_ZmGGGxsioa7zLfZRfeeX0fYXKh9OiHpVpAdjo_ObvMPswH1zeTqxDBKx3NnXEfs9nvxIewho3LZq7Nv8U1cg1O2eyLCaACvEK7nbIBXj-eh-jmZPZ9epqfX83Ppp_Pc12UdcwV0YrxCigrFYiu7YqyKnQH0HSsapuGtR2IlqoKsChVWXPRNpwnomyKktSUHaLjje-wanpoNbg4KiuH0fRqvJdeGfnvjzNLufB3klaYCE6SwftHg9H_XEGIsjdBg7XKgV8FWTImCK0ES8q3f4_aznhKNgnoRpBSDGGETmoTH1JOk42VBMt1fTLVJ5_qS9Cn_6Ct7_Pydxv50iyWv8wIMvTK2rQSlfpWBcclkVywP52cqbI |
CitedBy_id | crossref_primary_10_1186_s12967_023_04455_2 crossref_primary_10_1200_JCO_2013_54_8115 crossref_primary_10_1016_j_vetimm_2012_11_009 crossref_primary_10_4161_onci_20249 crossref_primary_10_1089_mab_2013_0005 crossref_primary_10_1016_j_ejphar_2022_175219 crossref_primary_10_1053_j_jrn_2011_10_020 crossref_primary_10_3390_cells10102703 crossref_primary_10_1016_j_trsl_2022_12_004 crossref_primary_10_1371_journal_pone_0035280 crossref_primary_10_1016_j_pharmthera_2017_05_010 crossref_primary_10_1016_j_lfs_2014_11_011 crossref_primary_10_1002_acr_24728 crossref_primary_10_1096_fj_202000651 crossref_primary_10_1186_1471_2164_15_965 crossref_primary_10_1007_s12031_014_0280_0 crossref_primary_10_4049_jimmunol_1103031 crossref_primary_10_1016_j_bbrc_2018_02_035 crossref_primary_10_3390_ijms20010066 crossref_primary_10_4049_jimmunol_1000413 crossref_primary_10_3389_fimmu_2021_674739 crossref_primary_10_1097_MED_0b013e328341311d crossref_primary_10_1016_j_bbrc_2024_150386 crossref_primary_10_1111_cas_12601 crossref_primary_10_1093_ndt_gfx255 crossref_primary_10_1038_nrneph_2010_157 crossref_primary_10_1111_exd_13524 crossref_primary_10_1016_j_tice_2021_101683 crossref_primary_10_1053_j_ackd_2011_12_001 crossref_primary_10_1002_brb3_39 crossref_primary_10_1038_nrneph_2013_44 crossref_primary_10_1111_jorc_12231 crossref_primary_10_1096_fj_201600613R crossref_primary_10_1186_1471_2164_11_532 crossref_primary_10_1016_j_cellimm_2017_03_006 crossref_primary_10_1371_journal_pone_0012093 crossref_primary_10_1007_s12035_017_0707_z |
Cites_doi | 10.1172/JCI116391 10.1016/S1567-133X(02)00012-1 10.1615/CritRevEukaryotGeneExpr.v13.i24.180 10.2174/157016108783955374 10.1097/01.ASN.0000129337.50739.48 10.1615/CritRevEukaryotGeneExpr.v13.i24.130 10.1517/13543784.17.4.451 10.1097/01.mnh.0000168336.67499.c0 10.4049/jimmunol.179.9.5778 10.1002/ijc.2910600111 10.1016/j.trsl.2007.12.005 10.4049/jimmunol.178.10.6557 10.1182/blood-2006-11-053769 10.1089/jir.2005.25.227 10.1016/j.jhep.2004.12.021 10.1016/j.semnephrol.2004.06.026 10.1093/ndt/gfn486 10.1093/nar/29.9.e45 10.1681/ASN.2006121367 10.1074/jbc.M008539200 10.1002/jcp.20841 10.1074/jbc.M203171200 10.1681/ASN.2006080926 10.1093/ndt/gfn571 10.1002/jcb.1259 10.2215/CJN.03850907 10.1161/hy1001.096358 10.1016/S0167-0115(02)00288-4 |
ContentType | Journal Article |
Copyright | Copyright © 2010 by the American Society of Nephrology |
Copyright_xml | – notice: Copyright © 2010 by the American Society of Nephrology |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.2215/CJN.03390509 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1555-905X |
EndPage | 61 |
ExternalDocumentID | PMC2801651 19833906 10_2215_CJN_03390509 cjasn5_1_56 |
Genre | Journal Article |
GroupedDBID | - 0R 29B 2WC 53G 5GY 5VS AAWTL ADACO ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS BAWUL CS3 DIK DU5 EBS EJD F5P FH7 GX1 H13 HYE HZ KQ8 O9- OK1 P2P RHF RHI RPM TNP WOQ ZA5 --- 0R~ 6PF AAOCO AAQQT AAUIN AAYXX ABBLC ABJNI ABXYN ACLDA ACZKN AFEXH AFNMH AHOMT AHQVU BTFSW BYPQX CITATION ERAAH HZ~ OVD TEORI TR2 W8F CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c479t-a1ca358e237ae6fdf4784cfeebf38dbb3dfe6d2a8e067a7956db553587b471923 |
ISSN | 1555-9041 1555-905X |
IngestDate | Thu Aug 21 14:12:42 EDT 2025 Fri Jul 11 12:25:51 EDT 2025 Mon Jul 21 06:00:37 EDT 2025 Thu Apr 24 23:03:35 EDT 2025 Tue Jul 01 01:57:03 EDT 2025 Tue Jan 05 20:17:17 EST 2021 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c479t-a1ca358e237ae6fdf4784cfeebf38dbb3dfe6d2a8e067a7956db553587b471923 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://cjasn.asnjournals.org/content/clinjasn/5/1/56.full.pdf |
PMID | 19833906 |
PQID | 733612863 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2801651 proquest_miscellaneous_733612863 pubmed_primary_19833906 crossref_citationtrail_10_2215_CJN_03390509 crossref_primary_10_2215_CJN_03390509 highwire_smallpub2_cjasn5_1_56 |
ProviderPackageCode | RHF RHI CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20100101 2010-01-00 2010-Jan |
PublicationDateYYYYMMDD | 2010-01-01 |
PublicationDate_xml | – month: 01 year: 2010 text: 20100101 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationSeriesTitle | Original Articles |
PublicationTitle | Clinical journal of the American Society of Nephrology |
PublicationTitleAlternate | Clin J Am Soc Nephrol |
PublicationYear | 2010 |
Publisher | American Society of Nephrology |
Publisher_xml | – name: American Society of Nephrology |
References | Selim (R6-10-20230601) 2003; 13 Haralanova-Ilieva (R2-10-20230601) 2005; 42 Bostrom (R28-10-20230601) 1993; 91 Chung (R13-10-20230601) 2007; 109 Bandari (R4-10-20230601) 2003; 111 Bachner (R5-10-20230601) 2002; 1 Owen (R7-10-20230601) 2003; 13 Jofre (R22-10-20230601) 2006; 17 Chung (R14-10-20230601) 2007; 179 Efstratiadis (R15-10-20230601) 2008; 6 Kovesdy (R16-10-20230601) 2008; 17 Kovesdy (R17-10-20230601) 2008; 3 Porazko (R24-10-20230601) 2008; 24 Shikano (R3-10-20230601) 2001; 271 Abdelmagid (R10-10-20230601) 2007; 210 Hadjiargyrou (R11-10-20230601) 2002; 277 Al-Aly (R25-10-20230601) 2008; 151 Ripoll (R12-10-20230601) 2007; 178 Pfaffl (R21-10-20230601) 2001; 29 London (R27-10-20230601) 2004; 15 Weterman (R8-10-20230601) 1995; 60 London (R26-10-20230601) 2005; 14 Safadi (R1-10-20230601) 2001; 84 Jean (R23-10-20230601) 2008; 24 Towler (R29-10-20230601) 2007; 18 Vaziri (R20-10-20230601) 2004; 24 Nomiyama (R9-10-20230601) 2005; 25 Blacher (R18-10-20230601) 2001; 38 Foley (R19-10-20230601) 1998; 9 11641313 - Hypertension. 2001 Oct;38(4):938-42 7814155 - Int J Cancer. 1995 Jan 3;60(1):73-81 14696968 - Crit Rev Eukaryot Gene Expr. 2003;13(2-4):205-20 15213285 - J Am Soc Nephrol. 2004 Jul;15(7):1943-51 11328886 - Nucleic Acids Res. 2001 May 1;29(9):e45 11114299 - J Biol Chem. 2001 Mar 16;276(11):8125-34 18363512 - Expert Opin Investig Drugs. 2008 Apr;17(4):451-67 15812249 - J Interferon Cytokine Res. 2005 Apr;25(4):227-31 15763343 - J Hepatol. 2005 Apr;42(4):565-72 12638126 - Brain Res Gene Expr Patterns. 2002 Oct;1(3-4):159-65 18393910 - Curr Vasc Pharmacol. 2008 Apr;6(2):93-107 17259596 - J Am Soc Nephrol. 2007 Feb;18(2):369-73 11443763 - J Am Soc Nephrol. 1998 Dec;9(12 Suppl):S16-23 12609765 - Regul Pept. 2003 Mar 28;111(1-3):169-78 17130274 - J Am Soc Nephrol. 2006 Dec;17(12 Suppl 3):S274-80 12055193 - J Biol Chem. 2002 Aug 16;277(33):30177-82 17284525 - Blood. 2007 May 15;109(10):4320-7 18433704 - Transl Res. 2008 May;151(5):233-9 17034042 - J Cell Physiol. 2007 Jan;210(1):26-37 16205470 - Curr Opin Nephrol Hypertens. 2005 Nov;14(6):525-31 15490413 - Semin Nephrol. 2004 Sep;24(5):469-73 14696973 - Crit Rev Eukaryot Gene Expr. 2003;13(2-4):265-75 18045858 - Clin J Am Soc Nephrol. 2008 Jan;3(1):168-73 17947650 - J Immunol. 2007 Nov 1;179(9):5778-84 18775894 - Nephrol Dial Transplant. 2009 Feb;24(2):589-96 8473518 - J Clin Invest. 1993 Apr;91(4):1800-9 11746512 - J Cell Biochem. 2001;84(1):12-26 17475886 - J Immunol. 2007 May 15;178(10):6557-66 18852190 - Nephrol Dial Transplant. 2009 Mar;24(3):948-55 |
References_xml | – volume: 91 start-page: 1800 year: 1993 ident: R28-10-20230601 article-title: Bone morphogenic protein expression in human atherosclerotic lesions publication-title: J Clin Invest doi: 10.1172/JCI116391 – volume: 1 start-page: 159 year: 2002 ident: R5-10-20230601 article-title: mRNA expression of the murine glycoprotein (transmembrane) nmb (Gpnmb) gene is linked to the developing retinal pigment epithelium and iris publication-title: Brain Res Gene Expr Patterns doi: 10.1016/S1567-133X(02)00012-1 – volume: 13 start-page: 265 year: 2003 ident: R6-10-20230601 article-title: Anti-osteoactivin antibody inhibits osteoblast differentiation and function in vitro publication-title: Crit Rev Eukaryot Gene Expr doi: 10.1615/CritRevEukaryotGeneExpr.v13.i24.180 – volume: 6 start-page: 93 year: 2008 ident: R15-10-20230601 article-title: Atherogenesis in renal patients: A model of vascular disease? publication-title: Curr Vasc Pharmacol doi: 10.2174/157016108783955374 – volume: 15 start-page: 1943 year: 2004 ident: R27-10-20230601 article-title: Arterial calcifications and bone histomorphometry in end-stage renal disease publication-title: J Am Soc Nephrol doi: 10.1097/01.ASN.0000129337.50739.48 – volume: 13 start-page: 205 year: 2003 ident: R7-10-20230601 article-title: Identification and characterization of the genes encoding human and mouse osteoactivin publication-title: Crit Rev Eukaryot Gene Expr doi: 10.1615/CritRevEukaryotGeneExpr.v13.i24.130 – volume: 17 start-page: 451 year: 2008 ident: R16-10-20230601 article-title: Novel targets and new potential: Developments in the treatment of inflammation in chronic kidney disease publication-title: Expert Opin Investig Drugs doi: 10.1517/13543784.17.4.451 – volume: 14 start-page: 525 year: 2005 ident: R26-10-20230601 article-title: Arteriosclerosis, vascular calcifications, and cardiovascular disease in uremia publication-title: Curr Opin Nephrol Hypertens doi: 10.1097/01.mnh.0000168336.67499.c0 – volume: 179 start-page: 5778 year: 2007 ident: R14-10-20230601 article-title: Syndecan-4 mediates the coinhibitory function of DC-HIL on T cell activation publication-title: J Immunol doi: 10.4049/jimmunol.179.9.5778 – volume: 60 start-page: 73 year: 1995 ident: R8-10-20230601 article-title: nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts publication-title: Int J Cancer doi: 10.1002/ijc.2910600111 – volume: 151 start-page: 233 year: 2008 ident: R25-10-20230601 article-title: Arterial calcification: A tumor necrosis factor-alpha mediated vascular Wnt-opathy publication-title: Transl Res doi: 10.1016/j.trsl.2007.12.005 – volume: 178 start-page: 6557 year: 2007 ident: R12-10-20230601 article-title: GPNMB is induced in macrophages by IFN-gamma and lipopolysaccharide and acts as a feedback regulator of proinflammatory responses publication-title: J Immunol doi: 10.4049/jimmunol.178.10.6557 – volume: 109 start-page: 4320 year: 2007 ident: R13-10-20230601 article-title: DC-HIL is a negative regulator of T lymphocyte activation publication-title: Blood doi: 10.1182/blood-2006-11-053769 – volume: 25 start-page: 227 year: 2005 ident: R9-10-20230601 article-title: Identification of genes differentially expressed in osteoclast-like cells publication-title: J Interferon Cytokine Res doi: 10.1089/jir.2005.25.227 – volume: 42 start-page: 565 year: 2005 ident: R2-10-20230601 article-title: Expression of osteoactivin in rat and human liver and isolated rat liver cells publication-title: J Hepatol doi: 10.1016/j.jhep.2004.12.021 – volume: 24 start-page: 469 year: 2004 ident: R20-10-20230601 article-title: Oxidative stress in chronic renal failure: The nature, mechanism and consequences publication-title: Semin Nephrol doi: 10.1016/j.semnephrol.2004.06.026 – volume: 24 start-page: 589 year: 2008 ident: R24-10-20230601 article-title: IL-18 is involved in vascular injury in end-stage renal disease patients publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfn486 – volume: 29 start-page: e45 year: 2001 ident: R21-10-20230601 article-title: A new mathematical model for relative quantification in real-time RT-PCR publication-title: Nucleic Acids Res doi: 10.1093/nar/29.9.e45 – volume: 18 start-page: 369 year: 2007 ident: R29-10-20230601 article-title: Calciotropic hormones and arterial physiology: “D”-lightful insights publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2006121367 – volume: 271 start-page: 8125 year: 2001 ident: R3-10-20230601 article-title: Molecular cloning of dendritic cell-associated transmembrane protein, DC-HIL, that promotes RGD-dependent adhesion of endothelial cells through recognition of heparin sulfate publication-title: J Biol Chem doi: 10.1074/jbc.M008539200 – volume: 210 start-page: 26 year: 2007 ident: R10-10-20230601 article-title: Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function publication-title: J Cell Physiol doi: 10.1002/jcp.20841 – volume: 277 start-page: 30177 year: 2002 ident: R11-10-20230601 article-title: Transcriptional profiling of bone regeneration: Insight into the molecular complexity of wound repair publication-title: J Biol Chem doi: 10.1074/jbc.M203171200 – volume: 17 start-page: S274 year: 2006 ident: R22-10-20230601 article-title: Inflammatory syndrome in patients on hemodialysis publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2006080926 – volume: 24 start-page: 948 year: 2008 ident: R23-10-20230601 article-title: Peripheral vascular calcification in long-haemodialysis patients: Associated factors and survival consequences publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfn571 – volume: 84 start-page: 12 year: 2001 ident: R1-10-20230601 article-title: Cloning and characterization of osteoactivin, a novel cDNA expressed in osteoblasts publication-title: J Cell Biochem doi: 10.1002/jcb.1259 – volume: 3 start-page: 168 year: 2008 ident: R17-10-20230601 article-title: Battleground: Chronic kidney disorders mineral and bone disease—Calcium obsession, vitamin D, and binder confusion publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.03850907 – volume: 38 start-page: 938 year: 2001 ident: R18-10-20230601 article-title: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease publication-title: Hypertension doi: 10.1161/hy1001.096358 – volume: 111 start-page: 169 year: 2003 ident: R4-10-20230601 article-title: Hematopoietic growth factor inducible neurokinin-1 (HGFIN) gene: A transmembrane protein that is similar to neurokinin-1 interacts with substance publication-title: Regul Pept doi: 10.1016/S0167-0115(02)00288-4 – volume: 9 start-page: S16 year: 1998 ident: R19-10-20230601 article-title: Epidemiology of cardiovascular disease in chronic renal disease publication-title: J Am Soc Nephrol – reference: 18363512 - Expert Opin Investig Drugs. 2008 Apr;17(4):451-67 – reference: 15213285 - J Am Soc Nephrol. 2004 Jul;15(7):1943-51 – reference: 18045858 - Clin J Am Soc Nephrol. 2008 Jan;3(1):168-73 – reference: 11443763 - J Am Soc Nephrol. 1998 Dec;9(12 Suppl):S16-23 – reference: 17475886 - J Immunol. 2007 May 15;178(10):6557-66 – reference: 15763343 - J Hepatol. 2005 Apr;42(4):565-72 – reference: 17034042 - J Cell Physiol. 2007 Jan;210(1):26-37 – reference: 18433704 - Transl Res. 2008 May;151(5):233-9 – reference: 8473518 - J Clin Invest. 1993 Apr;91(4):1800-9 – reference: 14696968 - Crit Rev Eukaryot Gene Expr. 2003;13(2-4):205-20 – reference: 7814155 - Int J Cancer. 1995 Jan 3;60(1):73-81 – reference: 11746512 - J Cell Biochem. 2001;84(1):12-26 – reference: 18775894 - Nephrol Dial Transplant. 2009 Feb;24(2):589-96 – reference: 17259596 - J Am Soc Nephrol. 2007 Feb;18(2):369-73 – reference: 11641313 - Hypertension. 2001 Oct;38(4):938-42 – reference: 18393910 - Curr Vasc Pharmacol. 2008 Apr;6(2):93-107 – reference: 12055193 - J Biol Chem. 2002 Aug 16;277(33):30177-82 – reference: 14696973 - Crit Rev Eukaryot Gene Expr. 2003;13(2-4):265-75 – reference: 11328886 - Nucleic Acids Res. 2001 May 1;29(9):e45 – reference: 16205470 - Curr Opin Nephrol Hypertens. 2005 Nov;14(6):525-31 – reference: 15812249 - J Interferon Cytokine Res. 2005 Apr;25(4):227-31 – reference: 17947650 - J Immunol. 2007 Nov 1;179(9):5778-84 – reference: 17130274 - J Am Soc Nephrol. 2006 Dec;17(12 Suppl 3):S274-80 – reference: 17284525 - Blood. 2007 May 15;109(10):4320-7 – reference: 18852190 - Nephrol Dial Transplant. 2009 Mar;24(3):948-55 – reference: 12638126 - Brain Res Gene Expr Patterns. 2002 Oct;1(3-4):159-65 – reference: 12609765 - Regul Pept. 2003 Mar 28;111(1-3):169-78 – reference: 15490413 - Semin Nephrol. 2004 Sep;24(5):469-73 – reference: 11114299 - J Biol Chem. 2001 Mar 16;276(11):8125-34 |
SSID | ssj0044325 |
Score | 2.159727 |
Snippet | Hematopoietic growth factor-inducible neurokinin 1 (HGFIN), also known as Gpnmb and osteoactivin, is a transmembrane glycoprotein that is expressed in numerous... Background and objectives: Hematopoietic growth factor–inducible neurokinin 1 (HGFIN), also known as Gpnmb and osteoactivin, is a transmembrane glycoprotein... |
SourceID | pubmedcentral proquest pubmed crossref highwire |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 56 |
SubjectTerms | Cells, Cultured Humans Kidney Failure, Chronic - metabolism Macrophages - metabolism Membrane Glycoproteins Membrane Proteins - biosynthesis Middle Aged Monocytes - metabolism Original Up-Regulation |
Title | Upregulation of Monocyte/Macrophage HGFIN (Gpnmb/Osteoactivin) Expression in End-Stage Renal Disease |
URI | http://cjasn.asnjournals.org/content/5/1/56.abstract https://www.ncbi.nlm.nih.gov/pubmed/19833906 https://www.proquest.com/docview/733612863 https://pubmed.ncbi.nlm.nih.gov/PMC2801651 |
Volume | 5 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIiEuiDflsfIBJFCVtImd1xEtLWWllst2VU6REzvbotap-kCwP5VfwzjOwy1FC1yiKnYbp98Xe8aZ-Qah11xwwkMntcKIU4uKiFhh6jArTQmlIuE-EyrfeTT2hxN6PvWmrdZPI2ppt03s9PpoXsn_oArnAFeVJfsPyNY_CifgM-ALR0AYjn-F8WS11qXkS6sPHtA8_aEK3g1GTNXmmqmInOHHwadxsR2wkssE2j4DsrlKaPimdwX638to2CLqsS-5BSbolSroIItJsXmFU0kaVOmUhu6EkaIi61hQtR0hgC57e_cjpUwplHV7aYMFO6tjPMb5Rr30X7DOB7tzya7n63kd4LOTnS-7hslKZ1rpgdgdFWiwNvcuihC4vTiQm0dVzsqeZ0U9rZBlC_OcNzWncu83xuppWWuXH64WrhbWODsf2z1CIqWEY3YDrFfLgjlOFKr2I5LdB0tpHeCYfmUb6cVO7Pm30G0XXBi32knSVgKlpCgIXN-aTspQQ-qaAypEbfXV9y2nSs36mGd0GOBrWEwX99G90tXB7zVvH6CWkA_RnVEZzPEIcZO-OM9wRd9uQ15ckBe_LajbNYn7Dje0xXOJa9rigra4pO1jNBn0L86GVln0w0ppEG0t5qSMeKFwScCEn_GMBiFNMyGSjIQ8SQjPhM9dFgqws1gA7j1PPA--ESRgZ4G78gSdyFyKZwg7sBrDmpVRQQkFPzsiqnKh2wMLOvMz4rVRp_pD47RUxFeFWRYxeMYKiRiQiCsk2uhN3XullWD-0O-0wibeLNliAVC4sUGINsIVYjHM5eoFHZMi321iJU0K9qJP2uipBrC5UkmCNgr2oK07KJn4_RY5nxVy8W6oUhad5zeN6wW62zyjL9HJdr0Tr8Di3ianBXV_ARjs2ew |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Upregulation+of+Monocyte%2FMacrophage+HGFIN+%28Gpnmb%2FOsteoactivin%29+Expression+in+End-Stage+Renal+Disease&rft.jtitle=Clinical+journal+of+the+American+Society+of+Nephrology&rft.au=Madeleine+V.+Pahl&rft.au=Nosratola+D.+Vaziri&rft.au=Jun+Yuan&rft.au=Sharon+G.+Adler&rft.date=2010-01-01&rft.pub=American+Society+of+Nephrology&rft.issn=1555-9041&rft.eissn=1555-905X&rft.volume=5&rft.issue=1&rft.spage=56&rft_id=info:doi/10.2215%2FCJN.03390509&rft_id=info%3Apmid%2F19833906&rft.externalDBID=n%2Fa&rft.externalDocID=cjasn5_1_56 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1555-9041&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1555-9041&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1555-9041&client=summon |